Clinical trial discovery in plain English. Data sourced from ClinicalTrials.gov.

About Browse conditions ClinicalTrials.gov ↗

Stella is not a medical provider and does not give medical advice. AI-generated summaries are for informational purposes only. Always consult your doctor before making any healthcare decisions.

Sedation With Dexmedetomidine-esketamine Combination and Delirium in ICU Patients — Stella

Home/Older Patients/Sedation With Dexmedetomidine-esketamine Combination and Delirium in ICU Patients

View on ClinicalTrials.gov

Recruiting

Back to Older Patients trials

Sedation With Dexmedetomidine-esketamine Combination and Delirium in ICU Patients

Phase 4 — Post-approval study. The treatment has been approved, but researchers continue monitoring it in a large population over time.

Trial locations(1 site)

China

Peking University First Hospital, Beijing, Beijing Municipality

Key details

Phase

Post-approval study

Sponsor

Peking University First Hospital

Enrollment target

~100 participants

Started

October 2025

Primary completion

September 2026

Age range

60 Years and older

Last updated November 2025

Interested in joining?

Tell us you're interested and we'll help connect you with the research team. We'll never share your email without your permission.

Your name

Email address

Stella acts as an intermediary. Researcher contact info is never exposed.

Follow this trial

Get notified in plain English when this trial's status changes. No account required.